Janssen Pharmaceutica N.V.
Records under this name other than the patents Janssen Pharmaceutica N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 458 patents it holds.
Back to Janssen Pharmaceutica N.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,133,895 | Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases now held by Galapagos, N.V. In force · High confidence | In force | High confidence | |
| US 8,609,865 | Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 8,691,860 | Novel crystals and process of making 5-({(2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC ACID conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 8,859,604 | Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 9,115,091 | Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 9,364,489 | Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 9,789,125 | Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 7,799,824 | Quaternary Salt CCR2 Antagonists now held by Kenvue Brands LLC In force · High confidence | In force | High confidence | |
| US 7,994,206 | Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6- DIMETHYL-PHENYL)-PROPIONYL]-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid now held by Allergan Holdings Unlimited Company In force · High confidence | In force | High confidence | |
| US 8,426,434 | Crystalline Form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]-AMINO]-2-Pyrimidinyl]AMINO]BENZONITRILE conveyed to Tibotec Pharmaceuticals Ltd. - now held by Janssen Sciences Ireland Unlimited Company In force · High confidence | In force | High confidence |